CARLA HILL: Open Payments
NPI 1740024579 · BLUE ASH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 22 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $162 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $214 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
| Braeburn Inc. | 1 | $29 |
| Tris Pharma Inc | 1 | $23 |
| Lundbeck LLC | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, FANAPT, ABILIFY MAINTENA, UZEDY, INGREZZA, Jornay PM, BRIXADI.
Industry payments across OH — which companies pay providers there.
